Bladder dysfunction in a transgenic mouse model of multiple system atrophy

Movement Disorders

Volumn 28, Issue 3, 2013, Pages 347-355

  Boudes, Mathieu ^a,b   Uvin, Pieter ^a,b   Pinto, Silvia ^a   Voets, Thomas ^b   Fowler, Clare J ^c   Wenning, Gregor K ^d   De Ridder, Dirk ^a   Stefanova, Nadia ^d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Animal model; Cystometry; Postresidual volume; Synuclein; Urinary bladder

Indexed keywords

ALPHA SYNUCLEIN; PROTEOLIPID PROTEIN;

ANIMAL TISSUE; ARTICLE; BLADDER DYSFUNCTION; BLADDER FUNCTION; BLADDER WALL; CONTROLLED STUDY; DETRUSOR MUSCLE; DISEASE MODEL; DIURESIS; FEMALE; LAMINA PROPRIA; MALE; MICTURITION; MORPHOLOGY; MOUSE; NERVE DEGENERATION; NERVE FIBER; NEUROPATHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; SHY DRAGER SYNDROME; TRANSGENIC MOUSE; URINARY TRACT DISEASE; URODYNAMICS; WILD TYPE;

ACETYLCHOLINE; AGE FACTORS; ALPHA-SYNUCLEIN; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DIURESIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMAGE CYTOMETRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIPLE SYSTEM ATROPHY; MYELIN PROTEOLIPID PROTEIN; URINARY BLADDER; URINARY BLADDER DISEASES; UTERINE CONTRACTION;

EID: 84875510628     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25336     Document Type: Article

References (31)

1. Stefanova N, Bucke P, Duerr S, et al. Multiple system atrophy: an update. Lancet Neurol 2009;8:1172-1178.
2. Wenning GK, Colosimo C, Geser F, et al. Multiple system atrophy. Lancet Neurol 2004;3:93-103.
3. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
4. Inoue M, Yagishita S, Ryo M, et al. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol (Berl). 1997;93:585-591.
5. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004;127:2657-2671.
6. Halliday GM, Holton JL, Revesz T, et al. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol 2011;122:187-204.
7. Jecmenica-Lukic M, Poewe W, Tolosa E, et al. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 2012;11:361-368.
8. Kirchhof K, Apostolidis AN, Mathias CJ, et al. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res 2003;15:293-298.
9. Winge K and Fowler CJ. Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management. Mov Disord 2006;21:737-745.
10. Benarroch EE. Neural control of the bladder: recent advances and neurologic implications. Neurology 2010; 75:1839-1846.
11. Stefanova N, Tison F, Reindl M, et al. Animal models of multiple system atrophy. Trends Neurosci 2005;28:501-506.
12. Yazawa I, Giasson BI, Sasaki R, et al. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 2005;45:847-859.
13. Shults CW, Rockenstein E, Crews L, et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 2005;25:10689-10699.
14. Stefanova N, Reindl M, Neumann M, et al. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 2005;166:869-876.
15. Stefanova N, Reindl M, Neumann M, et al. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy. Mov Disord 2007;22:2196-2203.
16. Stefanova N, Fellner L, Reindl M, et al. Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons. Am J Pathol 2011;179:954-963.
17. Stefanova N, Kaufmann WA, Humpel C, et al. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol 2012;124:51-65.
18. Stemberger S, Poewe W, Wenning GK, et al. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol 2010;224:459-464.
19. Kahle PJ, Neumann M, Ozmen L, et al. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 2002;3:583-588.
20. Stefanova N, Eriksson H, Georgievska B, et al. Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Mov Disord 2010;25:S625.
21. Uvin P, Everaerts W, Pinto S, et al. The use of cystometry in small rodents: a study of bladder chemosensation. J Vis Exp 2012;66:e3869.
22. Watson, C, Paxinos, G, and Kayalioglu, G. The Spinal Cord. A Christopher and Dana Reeve Foundation Text and Atlas. London: Academic Press; 2008.
23. Franklin KBJ, Paxinos, G. The Mouse Brain in Stereotaxic Coordinates. London: Academic Press; 1997.
24. Soler R, Fullhase C, Santos C, et al. Development of bladder dysfunction in a rat model of dopaminergic brain lesion. Neurourol Urodyn 2011;30:188-193.
25. Kitta T, Matsumoto M, Tanaka H, et al. GABAergic mechanism mediated via D receptors in the rat periaqueductal gray participates in the micturition reflex: an in vivo microdialysis study. Eur J Neurosci 2008;27:3216-3225.
26. Yoshimura N, Kuno S, Chancellor MB, et al. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Br J Pharmacol 2003;139:1425-1432.
27. Garbern JY, Cambi F, Tang XM, et al. Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 1997;19:205-218.
28. Wakabayashi K, Mori F, Tanji K, et al. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 2010;120:1-12.
29. Abele M, Schulz JB, Burk K, et al. Nerve conduction studies in multiple system atrophy. Eur Neurol 2000;43:221-223.
30. Hamill RW, Tompkins JD, Girard BM, et al. Autonomic dysfunction and plasticity in micturition reflexes in human alpha-synuclein mice. Dev Neurobiol 2012;72:918-936.
31. Benarroch EE. Brainstem in multiple system atrophy: clinicopathological correlations. Cell Mol Neurobiol 2003;23:519-526.